Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study

por Huang, Chiun-Sheng, Yu, Alice L, Tseng, Ling-Ming, Chow, Louis W C, Hou, Ming-Feng, Hurvitz, Sara A, Schwab, Richard B, L Murray, James, Chang, Hsien-Kun, Chang, Hong-Tai, Chen, Shin-Cheh, Kim, Sung-Bae, Hung, Jung-Tung, Ueng, Shir-Hwa, Lee, Su-Hua, Chen, Chwen-Cheng, Rugo, Hope S
Publicado 2020